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Abstract
This work addresses the comparison of different strategies for improving biosensor performance
using nanomaterials. Glucose biosensors based on commonly applied enzyme immobilization
approaches, including sol–gel encapsulation approaches and glutaraldehyde cross-linking
strategies, were studied in the presence and absence of multi-walled carbon nanotubes
(MWNTs). Although direct comparison of design parameters such as linear range and
sensitivity is intuitive, this comparison alone is not an accurate indicator of biosensor efficacy,
due to the wide range of electrodes and nanomaterials available for use in current biosensor
designs. We proposed a comparative protocol which considers both the active area available for
transduction following nanomaterial deposition and the sensitivity. Based on the protocol, when
no nanomaterials were involved, TEOS/GOx biosensors exhibited the highest efficacy, followed
by BSA/GA/GOx and TMOS/GOx biosensors. A novel biosensor containing carboxylated
MWNTs modified with glucose oxidase and an overlying TMOS layer demonstrated optimum
efficacy in terms of enhanced current density (18.3 ± 0.5 μA mM−1 cm−2), linear range
(0.0037–12 mM), detection limit (3.7 μM), coefficient of variation (2%), response time (less
than 8 s), and stability/selectivity/reproducibility. H2O2 response tests demonstrated that the
most possible reason for the performance enhancement was an increased enzyme loading. This
design is an excellent platform for versatile biosensing applications.
1. Introduction
Glucose plays a central role in metabolism, and glycolytic
transport is commonly studied in cancer research (e.g.,
the Warburg effect), diabetes, and other cell/tissue culture
applications [5]. Electrochemical glucose biosensors are
a vital tool for measuring glucose for a wide range
of applications, including point of care diagnostics and
preventative disease research [7, 23]. Most biosensors
are based on enzymatic recognition of glucose by glucose
oxidase (GOx), where oxidation to gluconic acid produces
H2O2, which is detected using oxidative amperometry at
a potential of +0.5–0.8 V [43, 17, 28, 37]. As a result
of the ongoing research focused on the development of
glucose biosensors [13, 42, 15, 43, 28, 37, 9, 10], GOx
has emerged as the de facto standard enzyme for exploring
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oxidative enzyme immobilization strategies. While enzyme
immobilization protocols and transduction schemes are
not completely interchangeable, immobilization approaches
successfully demonstrated with glucose biosensors can
potentially be applied to other biosensors for sensing important
physiological compounds.
Enzymes such as GOx are typically immobilized on
electrodes (e.g. platinum discs) via chemical linkage [27, 9] or
physical entrapment within a polymeric matrix [28, 37, 33, 6].
Glutaraldehyde (GA) is a commonly used amine cross-
linking agent which links enzymes via Schiff bases [24].
Bovine serum albumin (BSA) is often used with GA to
solubilize/stabilize enzymes, because GA may potentially lead
to enzyme deformation and non-specific binding [16, 31].
Covalent immobilization via BSA/GA linkages significantly
improves the consistency of biosensors [34, 35, 27].
Silicate sol–gels formed by ethyl esters of orthosilicic
acid, including tetraethyl orthosilicate (TEOS) [33] and
tetramethyl orthosilicate (TMOS) [6], are commonly used
for immobilizing enzymes via physical adsorption, because
the hydrolysis/condensation reaction of sol–gels generates
a three-dimensional polymer matrix of silica. Molecules
immobilized in TEOS/TMOS polymers are not chemically
modified; thus the porous structure of the matrix entraps
enzymes while facilitating diffusion of analytes such as
glucose and H2O2 [32].
Sensor performance can be enhanced by incorporating
various nanomaterials [13, 28, 37, 43, 15, 9]. Carbon
nanotube (CNT) is a nanomaterial which enhances biosensor
performance by facilitating electron transfer [44, 43, 15].
The widespread use of CNTs in a variety of applica-
tions [12, 41] has improved our understanding of the
mechanisms involved in this facilitated electron transfer,
significantly improving the efficiency of enzymatic biosen-
sors [13, 10, 48, 9, 45, 44, 14, 27, 28, 36, 26]. When
used in biosensors, CNTs can directly immobilize enzymes by
forming highly porous and inert carbon matrices [45], which
provide enzyme immobilization via physical entrapment,
and/or peptide bond formation between enzymatic amine
groups and carboxyl groups of functionalized CNTs [13].
CNT matrices often include Nafion for charge exclusion
(e.g., ascorbate and acetaminophen) [29] and increased matrix
chemical/mechanical stability [20]. In addition, Nafion
is commonly used because it does not significantly swell
following immersion in aqueous solutions, and is highly
permeable to water [20, 4, 44, 39, 21]. Thus, Nafion is often
used in biosensors for incorporating relatively insoluble CNTs.
Due to the multitude of possible combinations for utilizing
these nanomaterials/polymers in biosensors, a comprehensive
comparison of rational fabrication schemes is needed for
developing reproducible and reliable enzymatic biosensors.
Sensitivity is the gold standard for comparing various
biosensor designs, although reported sensitivities for GOx
biosensors vary greatly, e.g., from 0.33 μA mM−1 in a study by
Tsai et al [39] to 2.11 μA mM−1 in a study by Hrapovic et al
[17]. Another parameter that is commonly used is electrode
surface area, which also varies greatly, e.g., from 12×10−2 cm2
in Wang et al [45] to 3.14 × 10−2 cm2 in Zhang et al [46]. The
synergy between active transduction area (i.e., surface area)
and properly immobilized enzymes (available binding pockets)
regulates overall biosensor efficacy. Although sensitivity is
commonly reported, there is currently not a consistent protocol
for comparing biosensor performance based on both sensitivity
and surface area.
This study compares the performance of commonly
used biosensor fabrication schemes utilizing MWNTs, silica
sol–gels (TEOS and TMOS), and BSA/GA enzymatic
linking. Direct comparison of biosensor efficiency based
on a comprehensive protocol which considers sensitivity and
effective surface area will lead to improved biosensor design
by the inclusion of nanomaterials. Using this approach, highly
efficient GOx biosensor design schemes can be extrapolated
to other enzymatic biosensors for the detection of analytes
such as adenosine triphosphate (ATP) [22], ethanol [1, 20] and
glutamate [4, 11, 27].
2. Materials and methods
2.1. Chemicals and reagents
Deionized water of resistivity 18.2 M cm (Milli-Q) was
used to prepare solutions. Glucose oxidase (E.C.1.1.3.4,
2000–10 000 units g−1, from Aspergillus niger), potassium
chloride (KCl, 99%), potassium ferricyanide (K3Fe(CN)6),
Nafion (5% wt/wt), tetraethyl orthosilicate (99%), tetram-
ethyl orthosilicate (99%), hydrochloric acid (HCl), hydrogen
peroxide (H2O2), bovine serum albumin and glutaraldehyde
(Grade II, 25% aqueous solution) were purchased from Sigma-
Aldrich (St Louis, MO). D-glucose and sodium chloride (NaCl)
were purchased from Mallinckrodt Baker, Inc (Phillipsburg,
NJ). Sodium phosphate (Na2HPO4 · 7H2O) and potassium
phosphate (KH2PO4, monobasic) were purchased from Fisher
Chemicals (Pittsburg, PA). PBS solution (0.01 M) was
prepared by dissolving 8 g NaCl, 1.15 g Na2HPO4, 0.2 g
KCl and 0.2 g KH2PO4 in 1 l deionized water. MWNTs
(–COOH functionalized MWNTs, 95 wt%, 8–15 nm OD) were
purchased from cheaptubes.com.
2.2. Fabrication of biosensors
A Pt electrode was used as the transduction element for the
biosensor, which consisted of a polished Pt plate (3 mm
diameter) soldered to a copper wire with a glass encapsulation.
Before modification, the Pt electrode was polished with 1,
0.3 and 0.05 μm alumina slurries for 1 min each, and then
ultrasonicated in ethanol and deionized water for 1 min each.
For the TEOS/GOx (or TMOS/GOx) biosensors, 1 ml of
TEOS (or 1 ml of TMOS) was mixed with 200 μl-DI (or 300 μl
for TMOS) and 25 μl (or 27 μl for TMOS) of 0.4 N HCl to
maintain the same molar ratio (1:2.48) between sol–gel and
H2O. This mixture was ultrasonicated for 15 min and aged at
4 ◦C for 72 h before use. The pre-treated solution (60 μl) was
then mixed with 60 μl of 46 mg-GOx/ml-PBS. Polished Pt
electrodes were then dipped into the mixture for 12 h and air
dried for 30 min before use.
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For the BSA/GA/GOx biosensors, a solution was prepared
by mixing 40 μl of 25 mg ml−1 BSA, 20 μl of 2.5%
glutaraldehyde (GA), and 60 μl of 46 mg-GOx/ml-PBS.
Polished electrodes were dipped into the mixture for 12 h, and
then taken out and air dried for 30 min before use.
For the bionanocomposite CNT–TMOS (or TEOS)
biosensors, MWNTs (2 mg) were mixed with 1 ml Nafion, and
ultrasonicated for 30 min. The MWNT/Nafion mixture (2 μl)
was deposited on the surface of a Pt electrode and air dried for
10 min. The electrode was then dipped in 46 mg-GOx/ml-PBS
solution for 1 h, and the electrode was then modified using
a TMOS (or TEOS) solution as described above. When not
in use, the biosensors were stored in 46 mg-GOx/ml-PBS
solution at 4 ◦C.
For the CNT–GA biosensors, MWNTs (2 mg) were mixed
with 1 ml Nafion, and ultrasonicated for 30 min. The
MWNT/Nafion mixture (2 μl) was deposited on the surface
of a Pt electrode and air dried for 10 min. A solution was
prepared by mixing 40 μl of 25 mg ml−1 BSA, 20 μl of
2.5% glutaraldehyde (GA), and 60 μl of 46 mg-GOx/ml-PBS.
Polished electrodes were dipped into the mixture for 12 h, and
then taken out and air dried for 30 min before use.
For Pt/MWNT/Nafion electrode, MWNT (2 mg) were
mixed with 1 ml Nafion, and ultrasonicated for 30 min. The
MWNT/Nafion mixture (2 μl) was deposited on the surface of
a Pt electrode and air dried for 10 min.
2.3. Calibration and selectivity
DC potential amperometry and cyclic voltammetry (CV) were
performed on a three electrode electrochemical (C-3) cell stand
(BASi, West Lafayette, IN). Ag/AgCl reference electrode and
auxiliary electrodes were purchased from BASi. DC potential
amperometry was carried out with a working potential of
+500 mV versus the Ag/AgCl reference electrode with a
sampling rate of 1 kHz. CV was carried out with 10 s quiet
time at different scan rates using methods common to the
literature [40].
Amperometric sensitivity toward glucose was determined
by measuring current at a constant working potential
(+500 mV) while sequentially adding glucose. Complete
mixing of the solution was ensured through constant stirring
at 400 rpm with a magnetic stirrer. The measured current
signal was allowed to reach steady state following each glucose
addition, and average current represents the arithmetic mean
of steady state observed current. For all experiments, steady
state was defined as less than a 3% change in measured current
for a 60 s time period. All error bars represent the standard
error of the mean (SEM), and n values are reported where
applicable. Average current versus glucose concentration was
used to characterize sensitivity, and the slope of each linear
calibration curve used to estimate sensitivity (nA mM−1).
For each enzyme immobilization approach, three replicate
biosensors were fabricated on the same electrode after it was
polished, and average sensitivity was reported. The difference
in performance was reported as the standard error of the mean
in sensitivity.
Selectivity over ascorbic acid and acetaminophen was
tested by calibrating via DC potential amperometry in the
presence of 6 μM ascorbic acid (physiological concentration)
and 10 μM acetaminophen (therapeutic concentration).
Ascorbic acid and acetaminophen were added to PBS solutions
containing 1 mM glucose.
2.4. Surface area and current density determination
Effective surface area was determined by CV in 4 mM
Fe(CN)3−6 /1 M KNO3 solution in the potential range of 0 to+650 mV. The reduction peak current (ip) was determined by
the Randles–Sevcik equation [2]
ip = (2.69 × 105)n3/2 D1/2C Av1/2 (1)
where n is the number of transferred electrons for the redox
reaction, D is the diffusion coefficient (6.70 × 10−6 cm2 s−1),
C is the molar concentration of ferricyanide (4 mM), A is the
effective surface area (cm2), and v is the scan rate (V s−1). For
CV using Fe(CN)3−6 , the value of n is equal to one, due to the
following half reaction taking place at the electrode:
Fe(CN)3−6 + e− → Fe(CN)4−6 . (2)
From equation (1), a well-established linear relationship
exists between ip and v1/2. By performing linear regression
for ip versus v1/2, the slope k can be obtained, and one may
express A as
A = k/((2.69 × 105)n3/2 D1/2C). (3)
A series of scan rates (v = 20, 50, 100, 125, 150 and
200 mV s−1) was used, and the corresponding ip recorded,
where the scan rates were similar to previous studies [40]. To
compare the efficiency of various electrode designs based on
sensitivity and surface area, the current density was defined as
K = i/A (4)
where K is the current density (μA mM−1 cm−2), i is the
amperometric sensitivity (μA mM−1) and A is the effective
surface area of the electrode after surface modification. This
parameter (K ) describes the efficacy of biosensors in terms of
sensitivity and surface area, and may be used across a wide
range of spatial scales (i.e., macrosensor and/or microsensor
applications).
2.5. Imaging
All field emission scanning electron microscopy (FESEM)
graphs of the bionanocomposite CNT–TMOS biosensor were
obtained from a Hitachi S-4800 microscope with a power
setting of 5.0 kV and magnification settings of 3.5k and 25k.
The biosensor was prepared on a Pt electrode, and fixed in a
vertical position for imaging (no additional preprocessing).
3. Results and discussion
3.1. Comparison of effective surface area
CVs for bare electrodes (specified radius of 1.5 mm) in
ferricyanide followed expected trends (appendix figure A.1(a)),
3
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Figure 1. Representative CV for a bare Pt electrode and a
Pt/MWNT/Nafion electrode in 4 mM K3Fe(CN)6/1 M KNO3 at a
scan rate of 200 mV s−1. Inset: exploded view of the reduction peak.
and plots of peak current versus square root of scan rate
were linear (appendix figure A.1(b)). Using equation (3), the
effective surface area and radius of the bare Pt electrode were
7.20 ± 0.18 mm2 and 1.51 ± 0.02 mm, respectively, validating
the use of the Randles–Sevcik approach for determining
electrode effective surface area. CV curves for bare Pt
and Pt/MWNT/Nafion electrodes in 4 mM Fe(CN)3−6 /1 M
KNO3 at a scan rate of 200 mV s−1 are presented in
figure 1. As expected, well-defined reduction and oxidation
peaks were observed, and the mean value of peak separation
for bare Pt (70.3 ± 1.0 mV) was higher than values for
Pt/MWNT/Nafion electrodes (62.7 ± 2.8 mV). This was
due to changes of the surface micro-structure layer on
the metal electrode which likely affected the semi-infinite
linear diffusion-controlled redox of Fe(CN)3−6 /Fe(CN)
4−
6 , and
resulted in a smaller peak separation [14]. As expected,
this indicated enhanced electrochemical reversibility for the
Pt/MWNT/Nafion electrode over the bare Pt electrode.
Using this technique, the electrode effective surface area
was determined for each sensor design following modification
using various nanomaterials/polymers/GOx. Immobilization
of MWNTs in the Nafion layer increased the effective area
(by an average of 11 ± 3%). These results were expected,
as CNTs facilitate enhanced electron transfer for the redox
process of Fe(CN)3−6 /Fe(CN)
4−
6 [15, 42–44], thus increasing
the effective surface area available for signal transduction.
Deposition of TEOS/GOx and TMOS/GOx layers reduced
electrode surface area by approximately 33±6% and 10±2%,
while deposition of BSA/GA/GOx layer reduced surface area
by an average of 15±6%. Composite design schemes utilizing
sol–gel layers (CNT–TEOS/CNT–TMOS) reduced the surface
area by an average of 29 ± 5% and 14 ± 3%, while a
composite design utilizing a covalent linking scheme (CNT–
GA) reduced the surface area by an average of 28 ± 10%. For
all composite designs, the effective surface area determined
by the Randles–Sevcik method was decreased compared with
Pt/MWNT/Nafion electrodes, due to a reduction in conductive
area by sol–gel and/or BSA–GA.
3.2. Comparison of different schemes
In the absence of CNTs, biosensor sensitivity was highly
dependent on the immobilization scheme (i.e., entrapment
in sol–gel versus covalent linking; figures 2(a) and (b)).
Biosensors utilizing TEOS exhibited the largest sensitivity
(1172.2 ± 256.9 nA mM−1), followed by BSA/GA/GOx
biosensors (620.1 ± 56.0 nA mM−1), and TMOS/GOx
biosensors (395.7 ± 41.6 nA mM−1). Sol–gel porosity
is influenced by the orthosilicate precursor, degree of
hydrolysis, and solution silica concentration [3]. The
TEOS/TMOS solution was prepared with approximately
1 mol of TEOS/TMOS to 2.48 mol of H2O. During the
hydrolysis reaction, H2O frees an ethanol or methanol group
respectively, leaving reactive hydroxyl (–OH) groups on the
silica molecule. These groups interact via polycondensation
reactions to form the silica network. The most likely reason
for TEOS/GOx biosensors to exhibit a higher glucose response
over TMOS/GOx was that the TEOS layer had a wider range
of porosities than the TMOS layer because of the slower
hydrolysis and condensation reactions for TEOS due to steric
hindrance by the larger ethoxy group [25], leading to a higher
probability of enzyme entrapment within the TEOS matrix.
This was supported by the fact that TMOS/GOx biosensors
had a higher effective surface area compared with TEOS/GOx
biosensors. Immobilization of GOx with GA produced a
sensitivity lower than entrapment in TEOS, but higher than
TMOS (all response times were less than 8 s in the 0–500 μM
range).
Sensitivity was increased by an average of 181% and
41% for TMOS and BSA/GA biosensors when CNTs were
incorporated in the matrix (1110.1 ± 15.4 nA mM−1 and
873.7±105.5 nA mM−1) (figures 2(c) and (d)). No significant
increase in sensitivity was noted for TEOS designs including
CNTs, although the porosity of the matrix did not play as
significant of a role when CNTs were incorporated into the
matrix (average sensitivity for CNT–TEOS biosensors was
1017.7 ± 46.6 nA mM−1). Response time for sensors utilizing
CNTs was less than 8 s.
Although the effective surface areas of biosensor designs
varied (calculated by the Randles–Sevcik method), calculation
of current density using equation (4) indicated that biosensors
utilizing TEOS exhibited the largest current density (24.3 ±
3.3 μA mM−1 cm−2) (figure 3(a)), followed by BSA/GA/GOx
biosensors (10.4 ± 0.2 μA mM−1 cm−2), and TMOS/GOx
biosensors (6.2±0.5 μA mM−1 cm−2). The enhanced relative
efficiency of TEOS/GOx biosensors is attributed to entrapment
of enzymes within the porous TEOS sol–gel matrix.
The average current densities for CNT-based designs
utilizing TEOS (19.1 ± 0.5 μA mM−1 cm−2), TMOS (18.3 ±
0.5 μA mM−1 cm−2) and BSA/GA (18.2 ± 4.1 μA mM−1
cm−2) immobilization schemes were not statistically different
when analyzed using ANOVA (p < 0.05, α = 0.05).
Although TEOS/GOx biosensors exhibited an average current
density higher than CNT–TMOS biosensors, the standard
error of the mean was significantly higher. The CNT–TMOS
bionanocomposite resulted in more consistent biosensor
performance, which is critical for research and clinical
4
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Figure 2. (a) Representative DC amperometry for glucose biosensor designs incorporating TEOS/GOx, TMOS/GOx, and BSA/GA/GOx.
(b) Linear regression for average current versus glucose concentration (n = 60 steady state values for three replicate biosensors).
(c) Representative current response to successive additions of 100 μM glucose for CNT–TMOS, CNT–TEOS and CNT–GA at a working
potential of +500 mV. (d) Linear regression for average current versus glucose concentration for each CNT biosensor design. All error bars
represent standard error of the arithmetic mean.
Figure 3. (a) Average current density for biosensor design schemes, (b) FESEM image of CNT–TMOS (scale bar represents 5 μm), and
(c) exploded view of CNT–TMOS biosensor (scale bar represents 750 nm).
5
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Figure 4. Representative plots demonstrating (a) the dynamic range for a CNT–TMOS biosensor, and (b) average current concentration plots
for CNT–TMOS biosensor designs and exponential fits for average current versus glucose concentration up to 35 mM. The square indicates
the upper detection limit (UDL). Inset: linear regression for average current versus glucose concentration up to 12 mM (UDL).
applications. For brevity, the remainder of analyses will
address CNT–TMOS biosensors.
FESEM imaging indicated that the TMOS layer deposited
on CNT/Nafion matrices was highly porous (figures 3(b)
and (c)). The dynamic range of the CNT–TMOS biosensors
was measured from 0 to 35 mM. The lower detection limit
(determined using the σ3 or 99% confidence method) was
determined to be 3.7 μM, and the upper detection limit
(determined using the tangential technique) was 12 mM
(figure 4). This linear range covers the glucose concentration
range found in human blood [7] and most cell culture
media [37]. The response was exponential above 12 mM
due to a combination of (i) reduced diffusive transport at
the electrode surface (collapse of concentration gradient),
(ii) oxygen limitations, and (iii) saturation of active enzyme
binding sites. The linear range for CNT–sol–gel biosensors
was significantly larger than that for CNT–GA biosensors
(1.9 μM to 5 mM), demonstrating the wide range of in vivo
and in vitro applications which can utilize this fabrication
scheme.
Selectivity was determined by comparing response to
glucose, ascorbic acid (6 μM, physiological concentration),
and acetaminophen (10 μM, therapeutic concentration) for
CNT–TMOS biosensors (figure 5). The current signals
obtained for ascorbic acid and acetaminophen were 7.6% and
9.9% of that obtained for 1 mM glucose (typical concentration
in RPMI 1640 medium for β-cell culture [37]), demonstrating
desirable selectivity for glucose over common interferents
typically found in blood samples. In part, the selectivity can
be attributed to the negatively charged Nafion layer, which
repels negatively charged molecules such as ascorbic acid and
acetaminophen [29].
Although previously reported designs were successful
for specific research applications, many are not well suited
for a wide range of uses. This is in part due to
the lack of a specific protocol for reporting biosensor
performance (based on sensitivity and modified effective
surface area). As demonstrated in table 1, head-to-
head comparison of various designs is difficult based
Figure 5. Selectivity test for the CNT–TMOS biosensor over 6 μM
ascorbic acid and 10 μM acetaminophen in PBS. The current signals
obtained for ascorbic acid and acetaminophen were 7.6% and 9.9%
of those obtained for 1 mM glucose.
on sensitivity alone (even when considering electrode
radius). In comparison to previous designs incorporating
nanomaterials, the CNT–TMOS scheme displayed improved
sensitivity, current density, detection limit and linear response
range (table 1). Fabrication schemes including CNTs
and sol–gel layers demonstrated improved current density
over other designs in the current literature [39, 46].
Utilization of Pt improved electrochemical transduction due
to the enhanced electrocatalytic capabilities [19] relative to
electrodes comprised of GC [39, 47] or Au [46, 45]. GC is one
of the most commonly used electrode materials [13], although
the brittleness of carbon makes miniaturization difficult.
Although designs by Hrapovic et al utilizing GC electrodes
found a lower limit of detection [17], the linear sensing range
did not cover expected blood glucose concentration. The
stability of the CNT–TMOS design was quantified using DC
potential amperometry for three consecutive days (n = 3
biosensors), and the results indicated no significant change in
6
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Figure 6. Representative DC amperometric response toward H2O2 at +500 mV for (a) a bare Pt electrode, a Pt/MWNT/Nafion electrode and
a Pt/Nafion electrode, (b) a TMOS/GOx biosensor and a CNT–TMOS biosensor, (c) a TEOS/GOx biosensor and a CNT–TEOS biosensor, and
(d) a BSA/GA/GOx biosensor and a CNT–GA biosensor.
Table 1. Comparison of biosensor designs incorporating various nanomaterials to fabrication schemes in the current literature. The current
















CNT–TMOS 1110.1 ± 15.4 7.07 15.8 ± 0.2 18.3 ± 0.5 3.7 0.0037–12 This work
CNT–GA 873.7 ± 105.5 7.07 12.4 ± 1.5 18.2 ± 4.1 1.9 0.0019–5 This work
TEOS/GOx 1172.2 ± 256.9 7.07 16.6 ± 3.6 24.3 ± 3.3 2 0.002–8 This work
Au/cystamine/GOx — 3.14 — 8.8 ± 0.2 8.2 0.02–5.7 [46]
Nafion/GOx/GNPs/GCE — 7.07 — 6.5 34 up to 6 [47]
MWNT/Nafion/GOx/GCE 330 7.07 4.7 — 4 up to 2 [39]
Au/MWNT/GOx 1700 12 14.2 — 10 0.05–13 [45]
SWNT/PtNP/GCE/GOx 2110 7.07 29.7 75.4 0.5 0.0005–5 [17]
sensitivity over a three day period (average relative standard
error of 2%). After 45 days of storage in 46 mg-GOx/ml-PBS
at 4 ◦C, the sensitivity was reduced by 58%, which may be
due to the loss of enzyme bioactivity during storage. This
improvement in stability is significant, as previous design
schemes not including sol–gel layers reported a 40% decrease
in sensitivity after 50 min [38].
For all of the designs studied herein, the use of CNTs had a
much larger effect on biosensor efficiency than design schemes
using various combinations of (nano)materials. To explore
the electrocatalytic activity of CNTs on the electrooxidation
of the intermediate H2O2, amperometric H2O2 sensitivities
of Pt electrodes modified with different composite layers
were measured. Bare Pt electrodes had a higher average
H2O2 sensitivity (42.0 ± 0.8 nA μM−1) over Pt/Nafion
electrodes (10.3 ± 2.2 nA μM−1), because Nafion formed
a barrier which decreased H2O2 diffusion [30] (figure 6(a)).
Pt/MWNT/Nafion electrodes exhibited an average sensitivity
(20.9 ± 0.5 nA μM−1) higher than Pt/Nafion, although the
sensitivity was lower than bare electrodes (figure 6(a)). This
demonstrated that the MWNTs catalyzed the electrooxidation
of H2O2, probably due to the oxygenated species on tube ends,
which had been shown to increase electron transfer during
H2O2 oxidation [8].
Glucose was measured through two steps. The first
step was the conversion of glucose into H2O2 by GOx
(biorecognition), and the second step was the electrooxidation
of H2O2. Although the CNT–TMOS biosensors exhibited
7
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enhanced glucose sensing performance over TMOS/GOx,
biosensors modified with CNT–TMOS bionanocomposite
exhibited lower H2O2 response (12.8 ± 1.9 nA μM−1) than
TMOS/GOx composite (28.6 ± 1.1 nA μM−1), demonstrating
that the second step of glucose sensing (electrooxidation) was
not enhanced for the bionanocomposite (figure 6(b)). This was
because although the MWNTs increased the electrochemical
transduction, the diffusion barrier by Nafion within the
bionanocomposite resulted in a H2O2 response lower than
TMOS/GOx. Thus, the reason for the enhanced glucose
sensing performance of the CNT–TMOS over the TMOS/GOx
might be improved biorecognition due to an increased GOx
loading or better preserved GOx activity. Since TMOS sol–
gel is well known for preserving GOx activity even as well
as buffer solution [18], the reason was most likely to be
an increased enzyme loading in the bionanocomposite. The
increased enzyme loading could be partially attributed to
the unique structure of the carboxylated MWNTs used in
this study, which is known for the highly porous/condensed
matrices, entrapping enzymes via electrostatic/hydrophobic
interactions and peptide bonds [13, 45]. Similar results on
H2O2 response were observed with other bionanocomposites,
where CNT–TEOS (18.0 ± 1.4 nA μM−1) had lower
H2O2 response than TEOS/GOx (23.1 ± 5.6 nA μM−1)
(figure 6(c)), and CNT–GA had lower H2O2 response (13.7 ±
2.6 nA μM−1) than BSA/GA/GOx (28.7 ± 6.0 nA μM−1)
(figure 6(d)).
Several available biosensor fabrication schemes incorpo-
rating nanomaterials were demonstrated in this work, and novel
biosensors could be developed based on the demonstrated
designs. With the different designs, there were multiple
variables (e.g., enzyme concentration) that would result in
different biosensing performances. The optimization of
each design, such as using different types of CNTs (e.g.,
aligned single-walled carbon nanotubes) and the inclusion of
other nanomaterials (e.g., metal nanoparticle) could further
improve the biosensing performance [28, 37]. The proposed
protocol based on current density enabled the comparison
of different schemes, and also enabled the study of the
impacts of variables which were inherent in each scheme
by evaluating the integrative effect of these variables on
biosensing. This would lead to future improved biosensor
designs. In this study, a uniform GOx concentration and
dip coating were used for the enzyme immobilization of
each design, which further standardized the comparative
analysis.
4. Conclusions
In this study, glucose biosensors based on various nano-
material construction approaches (TEOS/GOx, TMOS/GOx,
BSA/GA/GOx, CNT–TMOS, CNT–TEOS and CNT–GA)
were studied and compared based on both sensitivity and
nanomaterial-modified surface area (i.e., current density). Per-
formance comparison protocols considering current density are
vital for accurate head-to-head comparison of biosensor design
schemes. Using this protocol, CNT–TMOS immobilized on
a Pt electrode was the optimum design in terms of enhanced
current density (18.3 ± 0.5 μA mM−1 cm−2), linear range
(0.0037–12 mM), low detection limit (3.7 μM), coefficient
of variation in sensitivity (2%), response time (less than
8 s), and reproducibility relative to other glucose biosensor
designs in the recent literature. The results from H2O2
response tests showed that the enhanced performance was
most likely due to an increased enzyme loading in the CNT–
TMOS bionanocomposite. The use of the anion repellent
Nafion layer repelled common electrochemical interferents
typically found in blood samples and resulted in desirable
selectivity. This bionanocomposite CNT–TMOS biosensor
is well suited for clinical and other practical biosensor
applications. The linear sensing range is indicative of the
wide range of in vivo and in vitro applications which can
utilize this fabrication scheme. Comparison of designs
based on rational combinations of nanomaterials using a
consistent protocol possesses great engineering significance
for optimization of biosensor fabrication in both academic and
industrial settings.
Appendix
Figure A.1. (a) Representative cyclic voltammogram in ferricyanide for a bare Pt electrode at various scan rates (mV s−1). (b) Linear
regression between the peak current (ip) and the square root of the scan rate (v1/2) for a 1.5 mm radius bare platinum electrode. The average
surface area determined using the Randles–Sevcik equation was 7.07 ± 0.16 mm2, and the average radius was 1.50 ± 0.02 mm.
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